Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait

Key facts

Where
Atlanta, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 90 years old?

Source: NCT07189819, who can take part

Where in United States

  • Emory Rehabilitation HospitalAtlanta, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Emory University
Trial code
NCT07189819
Record updated
16 July 2026
Original description
This study will compare the performance of a novel data-driven model-predictive controller (MPC) based functional electrical stimulation (FES) system versus a conventional FES system for footdrop correction during treadmill and overground walking tasks in people post-stroke.Read full original descriptionShow less

This study will compare the performance of a novel data-driven model-predictive controller (MPC) based functional electrical stimulation (FES) system versus a conventional FES system for footdrop correction during treadmill and overground walking tasks in people post-stroke.

Inclusion: >6 months since stroke; cortical or subcortical stroke; able to walk 10-meters with or without an assistive device; sufficient cardiovascular health and ankle stability to walk on treadmill without ankle orthosis; passive ankle range of motion to benefit from dorsiflexor FES assistance; resting heart rate 40-100 bpm.

Exclusion: musculoskeletal or medical conditions limiting walking; neurologic diagnoses other than stroke; score >1 on question 1b (does not know the current month and age) and >0 on question 1c (can not blink eyes and squeeze hands) on NIH Stroke Scale; cerebellar signs; inability to communicate with investigators; neglect/hemianopia; unexplained dizziness in past 6 months; sensory loss in paretic leg.

ClinicalTrials.gov NCT07189819